Accumulated evidence has revealed that CXCL8 promotes metastasis in many tumors, such as thyroid cancer (Song et al., 2019), prostate cancer (Baci et al., 2019), GC (Bae et al., 2019), and breast cancer (Aikins et al., 2017). Here, CXCL8 is linked to breast carcinoma.